Cargando…
Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer
OBJECTIVE: Oxygen is one of the most important environmental factors for tumor development. In this study, we examined pO(2) in malignant ascites in patients with peritoneal carcinomatosis. METHODS: In 21 patients with peritoneal dissemination of gastric cancer, ascitic fluid was collected and its p...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988845/ https://www.ncbi.nlm.nih.gov/pubmed/21103196 http://dx.doi.org/10.1159/000321262 |
_version_ | 1782192293317443584 |
---|---|
author | Emoto, Shigenobu Kitayama, Joji Yamaguchi, Hironori Ishigami, Hironori Kaisaki, Shoichi Nagawa, Hirokazu |
author_facet | Emoto, Shigenobu Kitayama, Joji Yamaguchi, Hironori Ishigami, Hironori Kaisaki, Shoichi Nagawa, Hirokazu |
author_sort | Emoto, Shigenobu |
collection | PubMed |
description | OBJECTIVE: Oxygen is one of the most important environmental factors for tumor development. In this study, we examined pO(2) in malignant ascites in patients with peritoneal carcinomatosis. METHODS: In 21 patients with peritoneal dissemination of gastric cancer, ascitic fluid was collected and its pH, pCO(2) and pO(2) were determined using a blood gas analyzer. RESULTS: In 21 patients, pH of malignant ascites was significantly lower than that of arterial blood (7.39 ± 0.07, 7.44 ± 0.02, p < 0.05). Accordingly, pCO(2) tended to be higher in ascites than in arterial blood. Unexpectedly, pO(2) in malignant ascites showed relatively high values (90.4 ± 27.72 mm Hg), which were mostly the same as those of arterial blood (97.09 ± 10.33 mm Hg, p = 0.858). Even in 19 patients whose samples were collected at bedside in room air, pO(2) of malignant ascites was 85.94 ± 23.94 mm Hg, which was patently higher than that in venous blood or in solid tumor tissues. CONCLUSION: Since the oxygen level critically affects the sensitivity of tumor cells to chemotherapeutic agents through metabolic transformation, the oxygenic condition in the peritoneal cavity may be beneficial for the progression of peritoneal metastasis, and also clinically important in considering the efficacy of chemotherapy. |
format | Text |
id | pubmed-2988845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-29888452010-11-22 Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer Emoto, Shigenobu Kitayama, Joji Yamaguchi, Hironori Ishigami, Hironori Kaisaki, Shoichi Nagawa, Hirokazu Case Rep Oncol Published: October 2010 OBJECTIVE: Oxygen is one of the most important environmental factors for tumor development. In this study, we examined pO(2) in malignant ascites in patients with peritoneal carcinomatosis. METHODS: In 21 patients with peritoneal dissemination of gastric cancer, ascitic fluid was collected and its pH, pCO(2) and pO(2) were determined using a blood gas analyzer. RESULTS: In 21 patients, pH of malignant ascites was significantly lower than that of arterial blood (7.39 ± 0.07, 7.44 ± 0.02, p < 0.05). Accordingly, pCO(2) tended to be higher in ascites than in arterial blood. Unexpectedly, pO(2) in malignant ascites showed relatively high values (90.4 ± 27.72 mm Hg), which were mostly the same as those of arterial blood (97.09 ± 10.33 mm Hg, p = 0.858). Even in 19 patients whose samples were collected at bedside in room air, pO(2) of malignant ascites was 85.94 ± 23.94 mm Hg, which was patently higher than that in venous blood or in solid tumor tissues. CONCLUSION: Since the oxygen level critically affects the sensitivity of tumor cells to chemotherapeutic agents through metabolic transformation, the oxygenic condition in the peritoneal cavity may be beneficial for the progression of peritoneal metastasis, and also clinically important in considering the efficacy of chemotherapy. S. Karger AG 2010-10-01 /pmc/articles/PMC2988845/ /pubmed/21103196 http://dx.doi.org/10.1159/000321262 Text en Copyright © 2010 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions. |
spellingShingle | Published: October 2010 Emoto, Shigenobu Kitayama, Joji Yamaguchi, Hironori Ishigami, Hironori Kaisaki, Shoichi Nagawa, Hirokazu Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer |
title | Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer |
title_full | Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer |
title_fullStr | Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer |
title_full_unstemmed | Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer |
title_short | Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer |
title_sort | analysis of po(2) in malignant ascites of patients with peritoneal dissemination of gastric cancer |
topic | Published: October 2010 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988845/ https://www.ncbi.nlm.nih.gov/pubmed/21103196 http://dx.doi.org/10.1159/000321262 |
work_keys_str_mv | AT emotoshigenobu analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer AT kitayamajoji analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer AT yamaguchihironori analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer AT ishigamihironori analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer AT kaisakishoichi analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer AT nagawahirokazu analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer |